Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Army
Healthtrust
Cipla
Fish and Richardson
Harvard Business School
QuintilesIMS
Chubb
Johnson and Johnson

Generated: April 23, 2018

DrugPatentWatch Database Preview

OSMITROL 20% IN WATER IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Osmitrol 20% In Water In Plastic Container patents expire, and what generic alternatives are available?

Osmitrol 20% In Water In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in OSMITROL 20% IN WATER IN PLASTIC CONTAINER is mannitol. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the mannitol profile page.
Summary for OSMITROL 20% IN WATER IN PLASTIC CONTAINER
Drug patent expirations by year for OSMITROL 20% IN WATER IN PLASTIC CONTAINER
Pharmacology for OSMITROL 20% IN WATER IN PLASTIC CONTAINER
Drug ClassOsmotic Diuretic
Mechanism of ActionOsmotic Activity
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for OSMITROL 20% IN WATER IN PLASTIC CONTAINER

US Patents and Regulatory Information for OSMITROL 20% IN WATER IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare OSMITROL 20% IN WATER IN PLASTIC CONTAINER mannitol INJECTABLE;INJECTION 013684-007 Approved Prior to Jan 1, 1982 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Covington
Cerilliant
Healthtrust
Cantor Fitzgerald
Mallinckrodt
Farmers Insurance
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.